VolitionRx Limited Interest Income, Other
VolitionRx Limited (VNRX) reported Interest Income, Other of $163 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2026-08-13
- VolitionRx Limited interest income, other for the quarter ending 2026-06-30 was $163.00, a 1.88% increase year-over-year.
- VolitionRx Limited interest income, other for the quarter ending 2026-03-31 was $16.00, a 89.87% decline year-over-year.
- VolitionRx Limited interest income, other for the quarter ending 2025-12-31 was $122.00, a 61.02% decline year-over-year.
- VolitionRx Limited interest income, other for the quarter ending 2025-09-30 was $160.00, a 69.81% decline year-over-year.
- VolitionRx Limited interest income, other for fiscal 2025 was $600.00, a 93.97% decline from fiscal 2024.
- VolitionRx Limited interest income, other for fiscal 2024 was $9.95K, a 89.34% decline from fiscal 2023.
- VolitionRx Limited interest income, other for fiscal 2023 was $93.32K, a 25.50% decline from fiscal 2022.
- VolitionRx Limited interest income, other for fiscal 2022 was $125.27K, a 4481.75% increase from fiscal 2021.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 12 month |
|---|---|---|---|---|
| 2026-06-30 | $163.00 10-Q · filed 2026-08-13 | $179.00 10-Q · filed 2026-08-13 | $301.00 derived: sum of 3 quarters · filed 2026-08-13 | $461.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $16.00 10-Q · filed 2026-05-14 | $138.00 derived: sum of 2 quarters · filed 2026-05-14 | $298.00 derived: sum of 3 quarters · filed 2026-05-14 | $458.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $122.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $282.00 derived: sum of 2 quarters · filed 2026-03-31 | $442.00 derived: sum of 3 quarters · filed 2026-08-13 | $600.00 10-K · filed 2026-03-31 |
| 2025-09-30 | $160.00 10-Q · filed 2025-11-13 | $320.00 derived: sum of 2 quarters · filed 2026-08-13 | $478.00 10-Q · filed 2025-11-13 | $791.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $160.00 10-Q · filed 2026-08-13 | $318.00 10-Q · filed 2026-08-13 | $631.00 derived: sum of 3 quarters · filed 2026-08-13 | $1.16K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $158.00 10-Q · filed 2026-05-14 | $471.00 derived: sum of 2 quarters · filed 2026-05-14 | $1.00K derived: sum of 3 quarters · filed 2026-05-14 | $1.45K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $313.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $843.00 derived: sum of 2 quarters · filed 2026-03-31 | $1.29K derived: sum of 3 quarters · filed 2026-03-31 | $9.95K 10-K · filed 2026-03-31 |
| 2024-09-30 | $530.00 10-Q · filed 2025-11-13 | $980.00 derived: sum of 2 quarters · filed 2025-11-13 | $9.63K 10-Q · filed 2025-11-13 | $17.97K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $450.00 10-Q · filed 2025-08-14 | $9.10K 10-Q · filed 2025-08-14 | $17.44K derived: sum of 3 quarters · filed 2025-08-14 | $17.67K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $8.65K 10-Q · filed 2025-05-15 | $16.99K derived: sum of 2 quarters · filed 2025-05-15 | $17.22K derived: sum of 3 quarters · filed 2025-05-15 | $44.33K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $8.34K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $8.57K derived: sum of 2 quarters · filed 2025-03-31 | $35.68K derived: sum of 3 quarters · filed 2025-03-31 | $93.32K 10-K · filed 2025-03-31 |
| 2023-09-30 | $230.00 10-Q · filed 2024-11-14 | $27.34K derived: sum of 2 quarters · filed 2024-11-14 | $84.99K 10-Q · filed 2024-11-14 | $152.14K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $27.11K 10-Q · filed 2024-08-14 | $84.76K 10-Q · filed 2024-08-14 | $151.91K derived: sum of 3 quarters · filed 2024-08-14 | $198.86K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $57.65K 10-Q · filed 2024-05-13 | $124.81K derived: sum of 2 quarters · filed 2024-05-13 | $171.75K derived: sum of 3 quarters · filed 2024-05-13 | $182.91K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $67.16K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $114.10K derived: sum of 2 quarters · filed 2024-03-25 | $125.26K derived: sum of 3 quarters · filed 2024-03-25 | $125.27K 10-K · filed 2024-03-25 |
| 2022-09-30 | $46.95K 10-Q · filed 2023-11-14 | $58.11K derived: sum of 2 quarters · filed 2023-11-14 | $58.11K 10-Q · filed 2023-11-14 | $58.34K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $11.16K 10-Q · filed 2023-08-14 | $11.16K 10-Q · filed 2023-08-14 | $11.39K derived: sum of 3 quarters · filed 2023-08-14 | $11.68K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $2.00 10-Q · filed 2023-05-10 | $233.00 derived: sum of 2 quarters · filed 2023-05-10 | $523.00 derived: sum of 3 quarters · filed 2023-05-10 | $1.01K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $231.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $521.00 derived: sum of 2 quarters · filed 2023-03-15 | $1.01K derived: sum of 3 quarters · filed 2023-03-15 | $2.73K 10-K · filed 2023-03-15 |
| 2021-09-30 | $290.00 10-Q · filed 2022-11-14 | $782.00 derived: sum of 2 quarters · filed 2022-11-14 | $2.50K 10-Q · filed 2022-11-14 | $3.04K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $492.00 10-Q · filed 2022-08-10 | $2.21K 10-Q · filed 2022-08-10 | $2.75K derived: sum of 3 quarters · filed 2022-08-10 | $5.55K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $1.72K 10-Q · filed 2022-05-11 | $2.26K derived: sum of 2 quarters · filed 2022-05-11 | $5.06K derived: sum of 3 quarters · filed 2022-05-11 | $12.80K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $539.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $3.34K derived: sum of 2 quarters · filed 2022-03-30 | $11.08K derived: sum of 3 quarters · filed 2022-03-30 | $49.49K 10-K · filed 2022-03-30 |
| 2020-09-30 | $2.80K 10-Q · filed 2021-11-10 | $10.54K derived: sum of 2 quarters · filed 2021-11-10 | $48.96K 10-Q · filed 2021-11-10 | $92.67K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $7.74K 10-Q · filed 2021-08-11 | $46.16K 10-Q · filed 2021-08-11 | $89.87K derived: sum of 3 quarters · filed 2021-08-11 | $117.50K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $38.41K 10-Q · filed 2021-05-11 | $82.13K derived: sum of 2 quarters · filed 2021-05-11 | $109.76K derived: sum of 3 quarters · filed 2021-05-11 | $139.22K derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $43.71K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $71.34K derived: sum of 2 quarters · filed 2021-03-22 | $100.80K derived: sum of 3 quarters · filed 2021-03-22 | $112.37K 10-K · filed 2021-03-22 |
| 2019-09-30 | $27.63K 10-Q · filed 2020-11-12 | $57.09K derived: sum of 2 quarters · filed 2020-11-12 | $68.66K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $29.46K 10-Q · filed 2020-08-13 | $41.02K 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | $11.56K 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |